Gilgamesh Announces Clinical Candidates For Two Programs With First In Human Dosing to Begin in Late 2022 Post published:March 24, 2022 Post category:Press Release
Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago Post published:March 24, 2022 Post category:Press Release
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK Post published:March 24, 2022 Post category:Press Release
Nova Mentis Begins Enrollment in North American Autism Study Post published:March 23, 2022 Post category:Press Release
Filament Health Announces Second Patent Issuance Post published:March 23, 2022 Post category:Press Release
Tryp Therapeutics Initiates Enrollment for Binge Eating Disorder Study in Partnership with University of Florida Post published:March 23, 2022 Post category:Press Release
Awakn Life Sciences Announces Closing of Private Placement Post published:March 22, 2022 Post category:Press Release
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments Post published:March 17, 2022 Post category:Press Release
MINDCURE Provides Update on Strategic Review Post published:March 16, 2022 Post category:Press Release
Nova Mentis Announces Closing of Non-Brokered Financing Post published:March 15, 2022 Post category:Press Release